COMP <GO>
FIX vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Comfort Systems USA Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FIX 3
— TMO 12
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: FIX
LAST: $1,232.66 (-7.06%) • MKT CAP: $46.40B
balance-sheet
8.06
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FIX VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FIX | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 22.00% | 41.00% | -19.00 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.50% | 9.30% | -4.80 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 30.4x | +64.60 | TMO | /valuation <GO> |
| Free Cash Flow Yield | 2.22% | 2.40% | -0.18 | TMO | /fcf-yield <GO> |
| Operating Margin | 11.40% | 17.40% | -6.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 55.80% | 15.10% | +40.70 | FIX | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 3.90% | -68.90 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.15% | 0.24% | -0.09 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 8.06 | 4.50 | +3.56 | FIX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.70% | +0.60 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.5 | 59.1 | -25.68 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 0.94 | +0.19 | FIX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 42.2x | 36.3x | +5.90 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.40B | $262.22B | -$215.82B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FIX REV | TMO REV | FIX GROSS % | TMO GROSS % | FIX FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.83B | $44.56B | 22.0% | 44.0% | $1.03B | $6.29B |
| FY 2024 | $7.03B | $42.88B | 21.0% | 44.0% | $738.0M | $7.27B |
| FY 2023 | $5.21B | $42.86B | 44.0% | 44.0% | $405.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FIX // BETA 1.13
TMO // BETA 0.94